StockData
Neurogene Inc. logo

Neurogene Inc. (NGNE) stock

NGNENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$22.15−0.78 (-3.40%)

Close on Nov 20, 2026Market cap $443.25MP/E –Yield –

Neurogene shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Neurogene's shares outstanding was 23M at Jun 30, 2026. For fiscal 2025 it was 21M, up 21.4% from the year before. Over ten years it grew 28.5% a year on average. The highest annual figure on record is 21M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202521M+21.4%
FY2024Dec 31, 202418M+59.1%
FY2022Dec 31, 202211M+0.3%
FY2021Dec 31, 202111M+6.2%
FY2020Dec 31, 202010M+91.7%
FY2019Dec 31, 20195M+14.9%
FY2018Dec 31, 20185M+0.3%
FY2017Dec 31, 20175M+24.1%
FY2016Dec 31, 20164M+49.5%
FY2015Dec 31, 20153M+45.8%
FY2014Dec 31, 20142M+2772.4%
FY2013Dec 31, 20130M0.0%
FY2012Dec 31, 20120M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202623M+7.1%
Q1 FY2026Mar 31, 202622M+6.2%
Q4 FY2025Dec 31, 202522M+13.4%
Q3 FY2025Sep 30, 202521M+24.9%
Q2 FY2025Jun 30, 202521M+24.3%
Q1 FY2025Mar 31, 202521M+24.2%
Q4 FY2024Dec 31, 202419M+4262.8%
Q3 FY2024Sep 30, 202417M+3714.3%
Q2 FY2024Jun 30, 202417M+52.8%
Q1 FY2024Mar 31, 202417M+52.9%
Q3 FY2023Sep 30, 20230M-96.0%
Q2 FY2023Jun 30, 20230M-96.0%
Q1 FY2023Mar 31, 202311M+0.5%
Q4 FY2022Dec 31, 202211M+0.3%
Q3 FY2022Sep 30, 202211M+0.3%
Q2 FY2022Jun 30, 202211M+0.3%
Q1 FY2022Mar 31, 202211M+0.4%
Q4 FY2021Dec 31, 202111M+0.9%
Q3 FY2021Sep 30, 202111M+1.8%
Q2 FY2021Jun 30, 202111M+11.4%
Q1 FY2021Mar 31, 202111M+11.7%
Q4 FY2020Dec 31, 202011M+56.8%
Q3 FY2020Sep 30, 202011M+106.7%
Q2 FY2020Jun 30, 202010M+109.8%
Q1 FY2020Mar 31, 202010M+108.9%
Q4 FY2019Dec 31, 20197M+48.0%
Q3 FY2019Sep 30, 20195M+11.3%
Q2 FY2019Jun 30, 20195M-1.3%
Q1 FY2019Mar 31, 20195M+0.2%
Q4 FY2018Dec 31, 20185M+0.3%
Q3 FY2018Sep 30, 20185M+0.3%
Q2 FY2018Jun 30, 20185M+1.7%
Q1 FY2018Mar 31, 20185M-99.9%
Q4 FY2017Dec 31, 20175M+0.1%
Q3 FY2017Sep 30, 20175M+32.6%
Q2 FY2017Jun 30, 20175M–
Q1 FY2017Mar 31, 20174.68B–
Q4 FY2016Dec 31, 20165M–
Q3 FY2016Sep 30, 20164M–

More Neurogene figures

See a number that looks wrong?